A Study to Test the Effects of Nezavist at Different Doses in Healthy Adults
A Phase 1a Randomized, Double-blind, Placebo-controlled, Single Site, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Nezavist in Healthy Adults
Sponsor: Lohocla Research Corporation
A PHASE1 clinical study on Healthy and Safety Evaluation of Escalating Doses, this trial is actively recruiting participants. The trial is conducted by Lohocla Research Corporation and has accumulated 5 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Nov 2025 — Present [monthly]
Recruiting PHASE1
-
Apr 2025 — Nov 2025 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Feb 2025 — Apr 2025 [monthly]
Not Yet Recruiting PHASE1
-
Dec 2024 — Feb 2025 [monthly]
Not Yet Recruiting PHASE1
-
Nov 2024 — Dec 2024 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Lohocla Research Corporation
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
For direct contact, visit the study record on ClinicalTrials.gov .